Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$117.66M$117.66Mderived+27.2% vs Q4 2014 Net Income$26.33M$26.33Mderived−1.8% vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$79,088,000+24.4% Operating Incomederived$37,801,000−2.7% Operating Cash Flowderived$37,139,000−2.1% Free Cash Flowderived$30,205,000−15.7% Margins · derivedGross margin67.2%−1.5 pt vs Q4 2014
Operating margin32.1%−9.9 pt vs Q4 2014
Net margin22.4%−6.6 pt vs Q4 2014
ended Jun 30, 2015 · filed Aug 31, 2015 · 62 d after period end